Cufstik AM Drop contains Ambroxol 7.5mg + Guaifenesin 12.5mg + Terbutaline 0.25mg, a combination used for relieving cough, loosening mucus, and easing bronchial spasms. It is effective in improving airway clearance and reducing respiratory discomfort.
Ambroxol works by breaking down mucus and facilitating its removal from the respiratory tract, Guaifenesin thins and loosens phlegm, while Terbutaline relaxes bronchial smooth muscles, improving airflow and easing breathing. This multi-action combination provides fast symptomatic relief.
This drop is commonly prescribed for patients with productive cough, bronchitis, and mild asthma, ensuring safer and convenient oral dosing. Its syrup-like liquid formulation is suitable for both children and adults.
For PCD pharma franchise partners, Cufstik AM Drop is a high-demand respiratory product, available at the best price for PCD pharma franchise. Its clinical efficacy, strong prescriber trust, and wide patient acceptance make it a valuable addition to any cough and pulmonary care product portfolio.
Common side effects may include mild nausea, headache, restlessness, or tremors. Rare but serious side effects include rapid heartbeat, severe allergic reactions, dizziness, or difficulty breathing. Patients should seek immediate medical attention if severe reactions occur.
Cufstik AM Drop is indicated for the management of productive cough, bronchitis, asthma-related cough, and other respiratory conditions associated with excessive mucus and airway constriction, as prescribed by a healthcare professional.
Cufstik AM Drop should be administered exactly as prescribed, usually with careful measurement using the provided dropper. Caution is advised in patients with heart disease, high blood pressure, diabetes, or hyperthyroidism. Avoid concurrent use with other bronchodilators unless advised by a doctor.
Store Cufstik AM Drop in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date printed on the bottle.